Fibromialgija: Razlika med redakcijama

OverlapsObstajajo havedoločene beenskupne drawnznačilnosti betweensindroma chronickronične fatigueutrujenosti syndromein and fibromyalgiafibromialgije. OneEna studyod foundraziskav increasedje levelspokazala ofpovečane pro-inflammatoryravni cytokinesprovnetnih in fibromyalgiacitokinov, whichki maybi increaselahko sensitivitypovečali toobčutljivost pain,za andbolečino contributein todoprinesli moodk razpoloženjskim problemstežavam.<ref name="sickness behavior">{{cite journal|last1=Dell'Osso|first1=Liliana|last2=Bazzichi|first2=Laura|last3=Baroni|first3=Stefano|last4=Falaschi|first4=Valentina|last5=Conversano|first5=Ciro|last6=Carmassi|first6=Claudia|last7=Marazziti|first7=Donatella|title=The inflammatory hypothesis of mood spectrum broadened to fibromyalgia and chronic fatigue syndrome|journal=Clinical and Experimental Rheumatology|date=1. January1. 2015|volume=33|issue=1 Suppl 88|pages=S109–116|issn=0392-856X|pmid=25786052}}</ref> IncreasedPoročali levelsso ofo povišanih ravneh IL-1RA, [[Interleukininterlevkin 6|interlevkina 6]] andin [[Interleukininterlevkin 8|interlevkina 8]] have been found.<ref name="cytokines">{{cite journal|last1=Rodriguez-Pintó|first1=Ignasi|last2=Agmon-Levin|first2=Nancy|last3=Howard|first3=Amital|last4=Shoenfeld|first4=Yehuda|title=Fibromyalgia and cytokines|journal=Immunology Letters|date=1. October10. 2014|volume=161|issue=2|pages=200–203|doi=10.1016/j.imlet.2014.01.009|issn=1879-0542|pmid=24462815}}</ref> NeurogenicDeloma inflammationnaj hasbi beenk proposedsimptomom asfibromialgije adoprineslo contributingnevrogeno factor to fibromyalgiavnetje.<ref>{{cite journal|last1=Littlejohn|first1=Geoffrey|title=Neurogenic neuroinflammation in fibromyalgia and complex regional pain syndrome|journal=Nature Reviews. Rheumatology|date=1. November11. 2015|volume=11|issue=11|pages=639–648|doi=10.1038/nrrheum.2015.100|issn=1759-4804|pmid=26241184}}</ref> ASistematični systematicpregled reviewraziskav foundpa mostje cytokinessicer levelspokazal, wereda similarso ravni večine citokinov primerljive med pacienti in patientsposamezniki andv kontrolnih controlsskupinah, exceptrazen forravni antagonista za receptor IL-1 receptorter antagonist,ravni IL-6 andin IL-8.<ref>{{cite journal|last1=Uçeyler|first1=Nurcan|last2=Häuser|first2=Winfried|last3=Sommer|first3=Claudia|title=Systematic review with meta-analysis: cytokines in fibromyalgia syndrome|journal=BMC Musculoskeletal Disorders|date=28. October10. 2011|volume=12|pages=245|doi=10.1186/1471-2474-12-245|issn=1471-2474|pmid=22034969|pmc=3234198}}</ref>